Maxcyte (MXCT) Shareholder's Equity (2019 - 2026)

Maxcyte (MXCT) Shareholder's Equity (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 52.06 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.98 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.67 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 7.20 Bn
10 Maxcyte 127.72 Mn 127.72 Mn 8.08 Mn 167.89 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 167.89 Mn
Dec 31, 2025 171.49 Mn
Sep 30, 2025 180.28 Mn
Jun 30, 2025 190.72 Mn
Mar 31, 2025 199.41 Mn
Dec 31, 2024 206.25 Mn
Sep 30, 2024 213.30 Mn
Jun 30, 2024 221.26 Mn
Mar 31, 2024 226.36 Mn
Dec 31, 2023 232.17 Mn
Sep 30, 2023 233.38 Mn
Jun 30, 2023 240.98 Mn
Mar 31, 2023 247.82 Mn
Dec 31, 2022 253.97 Mn
Sep 30, 2022 254.43 Mn
Jun 30, 2022 257.22 Mn
Mar 31, 2022 262.18 Mn
Dec 31, 2021 262.90 Mn
Sep 30, 2021 264.12 Mn
Jun 30, 2021 78.82 Mn